Shanghai Epiprobe Biotechnology Co., Ltd.
Shanghai Epiprobe Biotechnology Co., Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hematuria, Hemorrhage, Male Urogenital Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urination Disorders, Urogenital Diseases, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urinary system disorder, urothelial carcinoma | Not yet recruiting | Not stated | 2025-04-08 | NCT06912672 |